Common Fungicide Triggers Gut Colitis in Mice, Study Finds

If you've ever wondered whether pesticide residue on food could be quietly affecting your gut, a new mouse study offers one of the clearest mechanistic answers yet. Researchers found that chronic exposure to metalaxyl, one of the most widely used fungicides in modern agriculture, starved gut bacteria of the raw material they need to produce protective tryptophan metabolites, and that shortage triggered colitis-like inflammation. The same study found a fix: loading the diet with extra tryptophan restored the missing bacterial signals and reversed the damage. For anyone managing inflammatory bowel disease (IBD) or gut inflammation and wondering how diet and environmental exposures interact, this is a rare study that traces the entire chain from a specific chemical to a specific mechanism to a specific fix.

Key takeaways:

• A common agricultural fungicide (metalaxyl) disrupted gut bacteria and suppressed a protective signaling pathway, triggering colitis in mice.
• Transplanting the disrupted gut bacteria alone into healthy mice was enough to cause the same inflammation, showing the microbiome itself drives the damage.
• A tryptophan-enriched diet reversed the inflammation, even with the fungicide still present.
• This is a mouse-only study (six mice per group) with no human data yet, and it does not establish tryptophan supplements as an IBD treatment.

Metalaxyl Fungicide Disrupts Gut Tryptophan Metabolism

Metalaxyl, a systemic fungicide sprayed on crops from potatoes to grapes to tobacco, sets off a chain reaction that starts with gut bacteria and ends in intestinal inflammation, according to a study published in Frontiers in Nutrition by researchers at China Agricultural University. Mice given metalaxyl in their drinking water for 12 weeks developed disrupted gut microbiomes, with reduced bacterial diversity and a drop in tryptophan-metabolizing bacteria. That disruption suppressed activity of the aryl hydrocarbon receptor (AhR, a protein that senses bacterial byproducts and helps keep the gut lining intact and inflammation in check), and the mice developed measurable colon damage as a result.

Why This Matters for IBD and Colitis Risk

The findings matter most for people managing inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, because the study used IL-10 knockout mice, a standard model bred to be highly susceptible to spontaneous colitis, alongside ordinary mice. In the IBD-prone mice, even the lower of two metalaxyl doses tested, 0.8 mg per liter of drinking water, produced significant colon shortening, limited weight gain, and inflammatory cell infiltration in colon tissue. Ordinary mice only developed comparable damage at a tenfold higher dose (8 mg/L), suggesting existing gut vulnerability, not exposure level alone, determines whether this kind of chemical stress turns into disease. Metalaxyl itself is not an exotic exposure: the researchers cite survey data finding it in 97.92% of 192 bayberry samples tested, underscoring how common this dietary exposure already is.

Mouse Models, Fecal Transplants, and Rescue Experiments

What separates this from a typical association study is that the researchers tested causality at every step, not just correlation. First, they transplanted gut bacteria from metalaxyl-exposed mice into healthy, antibiotic-depleted recipient mice using fecal microbiota transplantation (FMT, a procedure that transfers gut bacteria from one animal to another), and confirmed the transplant successfully re-colonized recipients with matching bacterial communities. Those recipients developed the same colitis, shortened colons, elevated inflammatory markers, damaged tissue, as the originally exposed mice, even though they were never given metalaxyl themselves, showing the disrupted microbiome alone was enough to cause disease. Second, they injected mice with a synthetic AhR-activating compound alongside metalaxyl exposure; this restored AhR-driven gene activity and reversed the inflammation despite the fungicide still being present. Third, they swapped a standard mouse diet (2.7 g/kg tryptophan) for a tryptophan-enriched one (10 g/kg) during metalaxyl exposure, which produced the same rescue: colon length, inflammatory markers, and gene expression all returned to control-group levels. Each experiment used six mice per condition, a standard group size for this kind of mechanistic work, with results confirmed by two independent statistical tests.

What This Means If You're Managing IBD or Gut Symptoms

None of this means tryptophan supplements treat or prevent IBD in humans, and the study's authors are explicit that they have not tested that. What it does offer is a specific, testable mechanism, gut bacteria, tryptophan-derived metabolites, and AhR signaling, connecting an everyday chemical exposure to gut inflammation in a way that could eventually be checked in people. Tryptophan is an amino acid found in ordinary foods like turkey, eggs, dairy, oats, and soy, and there is no evidence from this study that eating more of these foods, or taking a tryptophan supplement, changes colitis risk or severity in humans. If you're managing IBD, this is a study worth mentioning to a gastroenterologist as context for how diet and environmental exposures might interact with gut bacteria, not a basis for starting a new supplement on your own.

Limitations: Small Mouse Study, No Human Trials Yet

The authors flag the biggest limitation themselves: this was a preventive intervention study in mice only, without dose-gradient screening beyond two exposure levels or any human clinical trial data, so species differences could change how, or whether, the same mechanism plays out in people. Each experimental group contained six mice, and the tryptophan and AhR-agonist treatments were given alongside metalaxyl exposure rather than after colitis was already established, so this tests prevention, not treatment of existing disease. It's also worth noting three of the paper's co-authors are employed by China National Tobacco Corporation, disclosed as a standard conflict-of-interest statement; the study itself was funded by China's National Key Research and Development Program, and the authors reported no financial relationship tied to the pesticide or supplement industries.

What Comes Next for Tryptophan and IBD Research

The researchers describe dietary tryptophan enrichment as safe, non-toxic, and easy to comply with, framing it as a plausible candidate for future clinical study rather than a finished treatment, with human trials and dose-response work as the logical next steps. Given that metalaxyl is one of many pesticides people are routinely exposed to through food, water, and air, the same gut-bacteria-to-AhR pathway is also a template other researchers could use to test whether different environmental chemicals affect IBD risk through the same route.

Common Questions

What is metalaxyl? Metalaxyl is a systemic fungicide used on crops like potatoes, grapes, and tobacco to control fungal disease; it dissolves easily in water, and residues have been detected on some produce and in soil and water.

What is the aryl hydrocarbon receptor (AhR)? AhR is a receptor protein in gut cells that responds to certain bacterial byproducts, including tryptophan metabolites, and helps maintain the gut lining and control inflammation; when the bacteria that make these byproducts are depleted, AhR activity drops.

Does this study prove pesticides cause IBD in humans? No. It shows a specific mechanism in mice, exposure to metalaxyl disrupted gut bacteria and tryptophan metabolism and caused colitis-like inflammation, that has not yet been tested in humans.

Should I take tryptophan supplements to protect my gut? The study doesn't support that. It tested a tryptophan-enriched mouse diet, not a human supplement, and any dietary change for a gut condition should be discussed with a doctor first.

References

1. Wei Sun, Yu Wang, Xin Zhang, et al. (2026). Dietary tryptophan ameliorates metalaxyl-induced colitis by restoring microbial tryptophan metabolism and aryl hydrocarbon receptor activation. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2026.1930000
2. eCFR — 40 CFR 180.408: Metalaxyl; tolerances for residues. ecfr.gov. https://www.ecfr.gov/current/title-40/chapter-I/subchapter-E/part-180/subpart-C/section-180.408